Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Toremifene> ?p ?o. }
Showing items 1 to 71 of
71
with 100 items per page.
- Toremifene abstract "Toremifene citrate is an oral selective estrogen receptor modulator (SERM) which helps oppose the actions of estrogen in the body. Licensed in the United States under the brand name Fareston, toremifene citrate is FDA-approved for use in advanced (metastatic) breast cancer. It is also being evaluated for prevention of prostate cancer under the brand name Acapodene.In 2007 the pharmaceutical company GTx, Inc was conducting two different phase 3 clinical trials; First, a pivotal Phase clinical trial for the treatment of serious side effects of androgen deprivation therapy (ADT) (especially vertebral/spine fractures and hot flashes, lipid profile, and gynecomastia) for advanced prostate cancer, and second, a pivotal Phase III clinical trial for the prevention of prostate cancer in high risk men with high grade prostatic intraepithelial neoplasia, or PIN. Results of these trials are expected by first quarter of 2008An NDA for the first application (relief of prostate cancer ADT side effects) was submitted in Feb 2009, and in Oct 2009 the FDA said they would need more clinical data, e.g. another phase III trial.".
- Toremifene atcPrefix "L02".
- Toremifene atcSuffix "BA02".
- Toremifene casNumber "89778-26-7".
- Toremifene chEBI "9635".
- Toremifene drugbank "DB00539".
- Toremifene fdaUniiCode "7NFE54O27T".
- Toremifene iupacName "2-{4-[(1Z)-4-chloro-1,2-diphenyl-but-1-en-1-yl]phenoxy}-N,N-dimethylethanamine".
- Toremifene pubchem "3005573".
- Toremifene thumbnail Toremifene.svg?width=300.
- Toremifene wikiPageID "3335295".
- Toremifene wikiPageRevisionID "590481517".
- Toremifene atcPrefix "L02".
- Toremifene atcSuffix "BA02".
- Toremifene c "26".
- Toremifene casNumber "89778".
- Toremifene chebi "9635".
- Toremifene chembl "1655".
- Toremifene chemspiderid "2275722".
- Toremifene cl "1".
- Toremifene drugbank "DB00539".
- Toremifene eliminationHalfLife "432000.0".
- Toremifene h "28".
- Toremifene hasPhotoCollection Toremifene.
- Toremifene inchi "1".
- Toremifene inchikey "XFCLJVABOIYOMF-QPLCGJKRBL".
- Toremifene iupacName "2".
- Toremifene kegg "D08620".
- Toremifene medlineplus "a608003".
- Toremifene molecularWeight "405.959".
- Toremifene n "1".
- Toremifene o "1".
- Toremifene proteinBound "more than 99.5%".
- Toremifene pubchem "3005573".
- Toremifene smiles "ClCCC=Cc3ccccc3".
- Toremifene stdinchi "1".
- Toremifene stdinchikey "XFCLJVABOIYOMF-QPLCGJKRSA-N".
- Toremifene unii "7".
- Toremifene verifiedrevid "470611877".
- Toremifene subject Category:Organochlorides.
- Toremifene subject Category:Phenol_ethers.
- Toremifene subject Category:Selective_estrogen_receptor_modulators.
- Toremifene type Abstraction100002137.
- Toremifene type Element114840755.
- Toremifene type Matter100020827.
- Toremifene type Part113809207.
- Toremifene type PhenolEthers.
- Toremifene type PhysicalEntity100001930.
- Toremifene type Quintessence114847103.
- Toremifene type Relation100031921.
- Toremifene type Substance100019613.
- Toremifene type Drug.
- Toremifene type DrugProduct.
- Toremifene type FunctionalSubstance.
- Toremifene comment "Toremifene citrate is an oral selective estrogen receptor modulator (SERM) which helps oppose the actions of estrogen in the body. Licensed in the United States under the brand name Fareston, toremifene citrate is FDA-approved for use in advanced (metastatic) breast cancer.".
- Toremifene label "Toremifene".
- Toremifene label "Toremifene".
- Toremifene label "Toremifeno".
- Toremifene label "Фарестон".
- Toremifene sameAs Toremifeno.
- Toremifene sameAs Toremifene.
- Toremifene sameAs m.096f39.
- Toremifene sameAs Q3993743.
- Toremifene sameAs Q3993743.
- Toremifene sameAs toremifene.
- Toremifene sameAs DB00539.
- Toremifene sameAs 5516.
- Toremifene sameAs Toremifene.
- Toremifene wasDerivedFrom Toremifene?oldid=590481517.
- Toremifene depiction Toremifene.svg.
- Toremifene isPrimaryTopicOf Toremifene.